Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.

Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.

Item
http://www.wikidata.org/entity/Q37862977
New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolismBeyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?Cannabinoids and value-based decision making: implications for neurodegenerative disorders.Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effectsCannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists.CB1 receptor antagonists: new discoveries leading to new perspectives.The unrelenting fall of the pharmacological treatment of obesity.Endocannabinoids and energy homeostasis: an update.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness.Re-visiting the Endocannabinoid System and Its Therapeutic Potential in Obesity and Associated Diseases.Synthesis of S-2-((S)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-(methyl-d3 )butanamide-d5 , octadeuterated JD5037.
P2860

Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.

Item
http://www.wikidata.org/entity/Q37862977
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@en
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@nl
type
label
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@en
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@nl
prefLabel
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@en
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Rimonabant redux and strategie ...... ist/inverse-agonist therapies.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698